<DOC>
	<DOCNO>NCT00259129</DOCNO>
	<brief_summary>This open-label , non-randomized Phase I study sorafenib 400 mg bid ( 2 x 200 mg tablet ) cancer patient . The primary objective study evaluate effect sorafenib cardiovascular safety parameter . The secondary objective evaluate safety , pharmacokinetics , anti-tumor activity sorafenib cancer patient</brief_summary>
	<brief_title>Effect BAY 43-9006 ( Sorafenib ) Cardiovascular Safety Parameters Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Sorafenib</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>Patients refractory solid cancer curative palliative measure fail patient standard treatment consider ineffective intolerable Histological cytological documentation cancer require Patients least one evaluable lesion . Lesions must evaluate Computed Tomography ( CT ) scan Magnetic Resonance Imaging ( MRI ) Life expectancy least 12 week Left ventricular ejection fraction ( LVEF ) &gt; =45 % assessed Baseline Multiple Gated Acquisition ( MUGA ) scan Adequate bone marrow , liver renal function assess follow laboratory requirement conduct within 7 day prior dose : Hemoglobin &gt; 9.0 g/dL Absolute neutrophil count ( ANC ) &gt; 1,500/mm3 Platelet count &gt; =100,000/dL Total bilirubin &lt; =1.5 time upper limit normal Alanine aminotransferase ( ALT ) Aspartate aminotransferase ( AST ) &lt; =2.5 x upper limit normal , except metastatic disease liver , case &lt; =5 x upper limit normal acceptable Prothrombin TimeInternational Normalized Ratio/Partial Thromboplastin Time ( PTINR/PTT ) &lt; 1.5 x upper limit normal . Patients therapeutically anticoagulated agent Coumadin heparin allow participate provide prior evidence underlie abnormality parameter exist . For patient anticoagulation therapy , least weekly evaluation perform International Normalized Ratio ( INR ) stable define local standard care Serum creatinine &lt; =1.5 x upper limit normal Colorectal cancer whether refractory Supine systolic blood pressure great 170 mmHg diastolic blood pressure great 100 mmHg ( mean duplicate reading ) Screening without antihypertensive Symptomatic metastatic brain meningeal tumor Pregnant breastfeeding patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>